These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 37980535)
1. Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils. Xie Y; Yao J; Yan M; Lin Y; Wei J; Wang H; Mao Y; Liu P; Li X J Transl Med; 2023 Nov; 21(1):832. PubMed ID: 37980535 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats. Li Y; Dong J; Zhou Y; Ye X; Cai Z; Zhang X; Shen L; Zhang M; Zhang W; Cai J Biochem Biophys Res Commun; 2021 Dec; 584():87-94. PubMed ID: 34775285 [TBL] [Abstract][Full Text] [Related]
4. Anti-fibrotic effect of intravenous umbilical cord-derived mesenchymal stem cells (UC-MSCs) injection in experimental rats induced liver fibrosis. Sungkar T; Putra A; Lindarto D; Juwita Sembiring R Med Glas (Zenica); 2021 Feb; 18(1):62-69. PubMed ID: 33078915 [TBL] [Abstract][Full Text] [Related]
5. TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation. Ding F; Liu Y; Li J; Wei X; Zhao J; Liu X; Zhang L Stem Cell Res Ther; 2024 Feb; 15(1):44. PubMed ID: 38360740 [TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis. Shi X; Zhang K; Qi Q; Zhou W; Yu F; Zhang Y Mol Biol Rep; 2024 Jun; 51(1):734. PubMed ID: 38874773 [TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism. Yao L; Hu X; Yuan M; Liu P; Zhang Q; Wang Z; Chen P; Xiong Z; Wu L; Dai K; Jiang Y Int Immunopharmacol; 2023 Oct; 123():110456. PubMed ID: 37494836 [TBL] [Abstract][Full Text] [Related]
8. Intravenous Umbilical Cord-derived Mesenchymal Stem Cells Transplantation Regulates Hyaluronic Acid and Interleukin-10 Secretion Producing Low-grade Liver Fibrosis in Experimental Rat. Sungkar T; Putra A; Lindarto D; Sembiring RJ Med Arch; 2020 Jun; 74(3):177-182. PubMed ID: 32801431 [TBL] [Abstract][Full Text] [Related]
9. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice. Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284 [TBL] [Abstract][Full Text] [Related]
10. [Umbilical cord mesenchymal stem cells and their association with liver fibrosis]. Tuo L; Zeng WZ; Xue HL; Wu XL Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):65-68. PubMed ID: 28297787 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase. Zhang L; Li Y; Guan CY; Tian S; Lv XD; Li JH; Ma X; Xia HF Stem Cell Res Ther; 2018 Feb; 9(1):36. PubMed ID: 29433563 [TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936 [TBL] [Abstract][Full Text] [Related]
13. Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice. Tu C; Wang Z; Xiang E; Zhang Q; Zhang Y; Wu P; Li C; Wu D Curr Stem Cell Res Ther; 2022; 17(6):564-575. PubMed ID: 35086457 [TBL] [Abstract][Full Text] [Related]
14. Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients. Wang D; Wang S; Huang S; Zhang Z; Yuan X; Feng X; Lu L; Sun L Stem Cells Transl Med; 2017 Sep; 6(9):1777-1785. PubMed ID: 28755405 [TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway. Chen P; Yuan M; Yao L; Xiong Z; Liu P; Wang Z; Jiang Y; Li L Biomed Pharmacother; 2024 Feb; 171():116133. PubMed ID: 38198960 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9. Fan J; Tang X; Wang Q; Zhang Z; Wu S; Li W; Liu S; Yao G; Chen H; Sun L Stem Cell Res Ther; 2018 Sep; 9(1):237. PubMed ID: 30223894 [TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes. Xue J; Gao J; Gu Y; Wang A; Yu S; Li B; Yin Y; Wang J; Su W; Zhang H; Ren W; Gu W; Lv Z; Mu Y; Cheng Y Stem Cell Res Ther; 2022 Mar; 13(1):109. PubMed ID: 35313972 [TBL] [Abstract][Full Text] [Related]
18. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway. Xuan J; Feng W; An ZT; Yang J; Xu HB; Li J; Zhao ZF; Wen W Mol Cell Biochem; 2017 May; 429(1-2):113-122. PubMed ID: 28181132 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice. Watanabe Y; Tsuchiya A; Seino S; Kawata Y; Kojima Y; Ikarashi S; Starkey Lewis PJ; Lu WY; Kikuta J; Kawai H; Yamagiwa S; Forbes SJ; Ishii M; Terai S Stem Cells Transl Med; 2019 Mar; 8(3):271-284. PubMed ID: 30394698 [TBL] [Abstract][Full Text] [Related]
20. Prior transfusion of umbilical cord mesenchymal stem cells can effectively alleviate symptoms of motion sickness in mice through interleukin 10 secretion. Zhu HS; Li D; Li C; Huang JX; Chen SS; Li LB; Shi Q; Ju XL World J Stem Cells; 2021 Feb; 13(2):177-192. PubMed ID: 33708346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]